ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 64 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 2.16 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $17,185,000 | +47.7% | 321,510 | +212.2% | 0.01% | +75.0% |
| Q4 2015 | $11,635,000 | -30.9% | 102,991 | -28.0% | 0.00% | -33.3% |
| Q3 2015 | $16,827,000 | +12.9% | 142,959 | -25.7% | 0.01% | +20.0% |
| Q2 2015 | $14,904,000 | +48.8% | 192,487 | +11.2% | 0.01% | +25.0% |
| Q1 2015 | $10,016,000 | +333.8% | 173,132 | +141.9% | 0.00% | +300.0% |
| Q4 2014 | $2,309,000 | +97.0% | 71,575 | +49.5% | 0.00% | – |
| Q3 2014 | $1,172,000 | -37.3% | 47,889 | -54.6% | 0.00% | -100.0% |
| Q2 2014 | $1,870,000 | +89.7% | 105,447 | +114.0% | 0.00% | – |
| Q1 2014 | $986,000 | +86.0% | 49,280 | +56.2% | 0.00% | – |
| Q4 2013 | $530,000 | +270.6% | 31,546 | +134.5% | 0.00% | – |
| Q3 2013 | $143,000 | +8.3% | 13,453 | -43.3% | 0.00% | – |
| Q2 2013 | $132,000 | – | 23,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |